MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | -31.1% | 120,200 | -5.7% | 0.00% | – |
| Q2 2023 | $74 | -18.7% | 127,400 | +34.7% | 0.00% | – |
| Q1 2023 | $91 | +4.6% | 94,605 | +15.1% | 0.00% | – |
| Q4 2022 | $87 | -99.9% | 82,200 | -2.7% | 0.00% | – |
| Q3 2022 | $90,000 | -29.7% | 84,500 | -4.1% | 0.00% | – |
| Q2 2022 | $128,000 | +19.6% | 88,100 | +47.1% | 0.00% | – |
| Q1 2022 | $107,000 | +72.6% | 59,900 | +79.3% | 0.00% | – |
| Q4 2021 | $62,000 | – | 33,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,040,529 | $1,852,000 | 0.61% |
| Sigma Planning Corp | 57,500 | $102,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,233 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,650 | $12,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,176 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 50,731 | $90,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 245,612 | $437,000 | 0.00% |
| STATE STREET CORP | 71,397 | $127,000 | 0.00% |
| North Star Investment Management Corp. | 250 | $0 | 0.00% |